{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T00:28:39Z","timestamp":1769300919946,"version":"3.49.0"},"reference-count":22,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CRR"],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:sec>\n<jats:title>Background\/Aims:<\/jats:title>\n<jats:p>Raynaud's phenomenon by episodically reversible constriction of\nthe arteries in the fingers and toes causes pain, numbness, sores, and gangrene. However, the treatment\nof Raynaud's phenomenon is one of the clinical issues. Recent studies have shown that botulinum\ntoxin is considered a potential and effective therapeutic option for improving finger blood\ncirculation in patients with Raynaud's syndrome. In this study, we sought to investigate the therapeutic\neffect of botulinum toxin type A on exacerbated Raynaud's phenomenon in patients with\nscleroderma.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>In this prospective study, 11 patients with systemic scleroderma who were referred due\nto aggravated Raynaud's were included. For all patients, questionnaires were filled up, and physical\nexamination was performed separately for both treatment and control hands, and then similar volumes\nof botulinum toxin type A (Botox) and normal saline were randomly injected.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The results showed that there was a significant difference in Raynaud's score (P = 0.001),\nQuick-Dash score (P = 0.01), Mc-Cabe cold score (P = 0.003), the mean frequency of recurrences\narracks (P = 0.01), pain (0.005) P = 0), skin color (P = 0.01), and duration of Raynaud's phenomenon\n(P = 0.006) between the intervention and control groups after two months.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Following Botox injection, a significant improvement in terms of various Raynaud's\nparameters as well as the clinical manifestations was observed in the intervention group. Together,\nbotulinum toxin type A could retrieve the hand function, the cold sensitivity, and the painful feeling\ncaused by Raynaud's syndrome.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1573397117666211012105611","type":"journal-article","created":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T23:09:19Z","timestamp":1634339359000},"page":"48-57","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Evaluation of Botulinum Toxin Type A and its Potential Effect on Exacerbated Raynaud's Phenomenon in Hospitalized Scleroderma Patients"],"prefix":"10.2174","volume":"18","author":[{"given":"Seyed Mostafa","family":"Seyedmardani","sequence":"first","affiliation":[{"name":"Internal Medicine Department, Urmia University of Medical Sciences, Urmia, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mir Amir","family":"Aghdashi","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Urmia University of Medical Sciences, Urmia, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaida","family":"Soltani","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Urmia University of Medical Sciences, Urmia, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Golshan Kamali","family":"Zonouz","sequence":"additional","affiliation":[{"name":"Emergency Medicine Department,\nUrmia University of Medical Sciences, Urmia, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.jaad.2008.06.004","volume":"59","author":"Bakst R.","year":"2008","unstructured":"Bakst R.; Merola J.F.; Franks A.G.; Sanchez M.; Raynaud\u2019s phenomenon: pathogenesis and management. J Am Acad Dermatol 2008,59(4),633-653","journal-title":"J Am Acad Dermatol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1016\/j.jhsa.2010.09.019","volume":"35","author":"Neumeister M.W.","year":"2010","unstructured":"Neumeister M.W.; Botulinum toxin type A in the treatment of Raynaud\u2019s phenomenon. J Hand Surg Am 2010,35(12),2085-2092","journal-title":"J Hand Surg Am"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1186\/s13075-019-2080-y","volume":"21","author":"Morrisroe K.","year":"2019","unstructured":"Morrisroe K.; Stevens W.; Sahhar J.; Ngian G-S.; Ferdowsi N.; Hill C.L.; Roddy J.; Walker J.; Proudman S.; Nikpour M.;  Arthritis Res Ther 2019,21(1),299","journal-title":"Arthritis Res Ther"},{"key":"ref=4","first-page":"599","author":"Iorio M.L.","year":"2012","unstructured":"Iorio M.L.; Masden D.L.; Higgins J.P.; Seminars in arthritis and rheumatism. Botulinum toxin A treatment of Raynaud\u2019s phenomenon: A review 2012,599-603","journal-title":"Botulinum toxin A treatment of Raynaud\u2019s phenomenon: A review"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.rdc.2015.04.005","volume":"41","author":"Cappelli L.","year":"2015","unstructured":"Cappelli L.; Wigley F.M.; Management of Raynaud phenomenon and digital ulcers in scleroderma. Rheumatic Dis Clin 2015,41(3),419-438","journal-title":"Rheumatic Dis Clin"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1097\/SAP.0000000000000614","volume":"75","author":"Chiou G.","year":"2015","unstructured":"Chiou G.; Crowe C.; Suarez P.; Chung L.; Curtin C.; Chang J.; Digital sympathectomy in patients with scleroderma: An overview of the practice and referral patterns and perceptions of rheumatologists. Ann Plast Surg 2015,75(6),637-643","journal-title":"Ann Plast Surg"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1002\/art.40123","volume":"69","author":"Bello R.J.","year":"2017","unstructured":"Bello R.J.; Cooney C.M.; Melamed E.; Follmar K.; Yenokyan G.; Leatherman G.; Shah A.A.; Wigley F.M.; Hummers L.K.; Lifchez S.D.; The therapeutic efficacy of botulinum toxin in treating scleroderma-associated Raynaud\u2019s phenomenon: A randomized, double-blind, placebo-controlled clinical trial. Arthritis Rheumatol 2017,69(8),1661-1669","journal-title":"Arthritis Rheumatol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1056\/NEJMcp013013","volume":"347","author":"Wigley F.M.","year":"2002","unstructured":"Wigley F.M.; Clinical practice. Raynaud\u2019s Phenomenon. N Engl J Med 2002,347(13),1001-1008","journal-title":"N Engl J Med"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.jhsa.2012.01.021","volume":"37","author":"Stone A.V.","year":"2012","unstructured":"Stone A.V.; Koman L.A.; Callahan M.F.; Eckman D.M.; Smith B.P.; Plate J.F.; Smith T.L.; The effect of botulinum neurotoxin-A on blood flow in rats: A potential mechanism for treatment of Raynaud phenomenon. J Hand Surg Am 2012,37(4),795-802","journal-title":"J Hand Surg Am"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/01.prs.0000244860.00674.57","volume":"119","author":"Van Beek A.L.","year":"2007","unstructured":"Van Beek A.L.; Lim P.K.; Gear A.J.L.; Pritzker M.R.; Management of vasospastic disorders with botulinum toxin A. Plast Reconstr Surg 2007,119(1),217-226","journal-title":"Plast Reconstr Surg"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/j.1365-2362.2004.01324.x","volume":"34","author":"Sycha T.","year":"2004","unstructured":"Sycha T.; Graninger M.; Auff E.; Schnider P.; Botulinum toxin in the treatment of Raynaud\u2019s phenomenon: A pilot study. Eur J Clin Invest 2004,34(4),312-313","journal-title":"Eur J Clin Invest"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.anplas.2011.11.001","volume":"58","author":"Serri J.","year":"2013","unstructured":"Serri J.; Legr\u00e9 R.; Veit V.; Guardia C.; Gay A.M.; Botulinum toxin type A contribution in the treatment of Raynaud\u2019s phenomenon due to systemic sclerosis. Ann Chir Plast Esthet 2013,58(6),658-662","journal-title":"Ann Chir Plast Esthet"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1177\/1753193413516242","volume":"39","author":"Uppal L.","year":"2014","unstructured":"Uppal L.; Dhaliwal K.; Butler P.E.; A prospective study of the use of botulinum toxin injections in the treatment of Raynaud\u2019s syndrome associated with scleroderma. J Hand Surg Eur Vol 2014,39(8),876-880","journal-title":"J Hand Surg Eur Vol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1097\/PRS.0b013e3181a80576","volume":"124","author":"Neumeister M.W.","year":"2009","unstructured":"Neumeister M.W.; Chambers C.B.; Herron M.S.; Webb K.; Wietfeldt J.; Gillespie J.N.; Bueno R.A.; Cooney C.M.; Botox therapy for ischemic digits. Plast Reconstr Surg 2009,124(1),191-201","journal-title":"Plast Reconstr Surg"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1056\/NEJMra1507638","volume":"375","author":"Wigley F.M.","year":"2016","unstructured":"Wigley F.M.; Flavahan N.A.; Raynaud\u2019s Phenomenon. N Engl J Med 2016,375(6),556-565","journal-title":"N Engl J Med"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"843","DOI":"10.2340\/00015555-2665","volume":"97","author":"Motegi S-I.","year":"2017","unstructured":"Motegi S-I.; Uehara A.; Yamada K.; Sekiguchi A.; Fujiwara C.; Toki S.; Date Y.; Nakamura T.; Ishikawa O.; Efficacy of botulinum toxin B injection for Raynaud\u2019s phenomenon and digital ulcers in patients with systemic sclerosis. Acta Derm Venereol 2017,97(7),843-850","journal-title":"Acta Derm Venereol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/01.prs.0000444918.38206.74","volume":"133","author":"Webb K.N.","year":"2014","unstructured":"Webb K.N.; Berry N.N.; Bueno R.A.; Neumeister M.W.; Abstract 5: A 28-Day Prospective, Randomized, Double-Blind, Placebo Controlled Clinical Trial of Botulinum Toxin Type A for Raynaud\u2019s Phenomen. Plast Reconstr Surg 2014,133(3),13","journal-title":"Plast Reconstr Surg"},{"key":"ref=18","volume":"2018","author":"Dhaliwal K.","year":"2018","unstructured":"Dhaliwal K.; Griffin M.; Denton C. P.; Butler P. E.; The novel use of botulinum toxin A for the treatment of Raynaud\u2019s phenomenon in the toes. Case Reports 2018,2018","journal-title":"Case Reports"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.semarthrit.2016.02.005","author":"Frantz C.","year":"2016","unstructured":"Frantz C.; Avouac J.; Distler O.; Amrouche F.; Godard D.; Kennedy A.T.; Connolly K.; Varga J.; Matucci-Cerinic M.; Allanore Y.;  Seminars in arthritis and rheumatism 2016,115-123","journal-title":"Seminars in arthritis and rheumatism"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0889-857X(03)00019-X","volume":"29","author":"Hummers L.K.","year":"2003","unstructured":"Hummers L.K.; Wigley F.M.; Management of Raynaud\u2019s phenomenon and digital ischemic lesions in scleroderma. Rheum Dis Clin North Am 2003,29(2),293-313","journal-title":"Rheum Dis Clin North Am"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/1346-8138.13030","volume":"43","author":"Motegi S.","year":"2016","unstructured":"Motegi S.; Yamada K.; Toki S.; Uchiyama A.; Kubota Y.; Nakamura T.; Ishikawa O.; Beneficial effect of botulinum toxin A on Raynaud\u2019s phenomenon in Japanese patients with systemic sclerosis: A prospective, case series study. J Dermatol 2016,43(1),56-62","journal-title":"J Dermatol"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.anplas.2011.11.001","author":"Serri J.","year":"2013","unstructured":"Serri J.; Legre R.; Veit V.; Guardia C.; Gay A.M.;  Annales de Chirurgie Plastique Esth\u00e9tique 2013,658-662","journal-title":"Annales de Chirurgie Plastique Esth\u00e9tique"}],"container-title":["Current Rheumatology Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573397117666211012105611","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/197181\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573397117666211012105611","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T09:24:24Z","timestamp":1656581064000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/197181\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573397117666211012105611","relation":{},"ISSN":["1573-3971"],"issn-type":[{"value":"1573-3971","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-11-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-23","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}